Skip to main content
Caplight Logo









Cardiomatics

Cardiomatics

Private
PolandHealthcare & Life Scienceshttps://cardiomatics.com/

Last Round

Seed

Aug 25, 2021

Total Funding Raised

$5.16M

Company Overview

Cardiomatics is a health technology company that provides a cloud-based, AI-powered platform for the analysis and interpretation of electrocardiogram (ECG) data.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

ECG analysiselectrocardiogram analysisECGmedical AIAI cardiologycardiac rhythm assessmentautomated ECG interpretationdigital healthhealthcare SaaSECG APIarrhythmia detectionmedical device softwareclinical decision supportusage-based billingtelecardiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiomatics Comparables

Compare Cardiomatics with similar companies based on industry and business-model similarity.

Cardiomatics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AccurKardia
90%
PulseAI
87%
Idoven
87%

Cardiomatics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 25, 2021
GrantAug 23, 2021
Pre SeedJul 23, 2019
GrantJul 12, 2019

Key People

Founding team and executive leadership

Rafal Samborski

Chief Executive Officer

Executive Team

Piotr Korzeniowski

Interim CFO

Executive Team

Cardiomatics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    Software received CE/MDR certification, classifying it as medical grade.

  • Aug 18, 2025

    Will be present at ESC Congress 2025 in Madrid, Spain.

Recent news

Latest coverage and updates

  • attends_eventJul 21, 2026

    Cardiomatics Arseus Medical Partnership will attend event ESC Congress 2026 on Aug 30th '26.

Cardiomatics Filings

Explore SEC and related filing metadata, where available.

Cardiomatics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cardiomatics's valuation, stock price, and market status.

Is Cardiomatics a public or private company?

Cardiomatics is a private company.

What is the current stock price of Cardiomatics?

Cardiomatics is a private company with no public stock price. No recent secondary market data is available.

How much is Cardiomatics worth (valuation)?

Valuation information for Cardiomatics is not publicly available.

Can I buy Cardiomatics stock?

Cardiomatics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cardiomatics's last funding round?

Cardiomatics's most recent funding round was Seed on August 25, 2021.

Who are the main investors in Cardiomatics?

Key investors in Cardiomatics include KAYA.

Will Cardiomatics IPO soon?

No public IPO plans have been announced for Cardiomatics.

How can I track Cardiomatics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cardiomatics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPoland
Employee Range21
Year Founded2017
Last FundingAug 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?